Effects of body composition and liver function after long-term pemafibrate treatment on dyslipidemia-associated non-alcoholic fatty liver disease

AIM OF THE STUDY: Owing to the association between non-alcoholic fatty liver disease (NAFLD) and dyslipidemia, there is a need for new treatment strategies to manage both conditions concomitantly. Our aim in this study was to evaluate the effectiveness of pemafibrate in alleviating dyslipidemia-asso...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishikawa, Toru, Terai, Nanako, Igarashi, Takanori, Yamazaki, Shun, Kobayashi, Takamasa, Sato, Toshifumi, Iwanaga, Akito, Sano, Tomoe, Yokoyama, Junji, Honma, Terasu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2023
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369653/
https://www.ncbi.nlm.nih.gov/pubmed/37502434
http://dx.doi.org/10.5114/ceh.2023.127813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369653/
https://www.ncbi.nlm.nih.gov/pubmed/37502434
http://dx.doi.org/10.5114/ceh.2023.127813

Ejemplares similares